Multimodal outpatient antibiotic stewardship to improve UTI care for veterans with neurogenic bladder
Official title: Evaluating a Multimodal Outpatient Antibiotic Stewardship Intervention to Improve Diagnosis and Treatment of Urinary Tract Infections in Veterans with Neurogenic Bladder
Funded at VA Eastern Colorado Health Care System · NIH-11343207 · Data updated 2026-11-12
A program to improve how UTIs are diagnosed and treated in veterans with neurogenic bladder who receive care outside hospital settings.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | VA Eastern Colorado Health Care System NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project start | July 1, 2026 |
| Project end | June 30, 2030 |
| Funding year | 2026 |
| NIH project number | 1I01RD002069-01A1 |
| Project ID | NIH-11343207 on NIH RePORTER |
Who could benefit from this research
✓Could help
Veterans with neurogenic bladder due to spinal cord injury or multiple sclerosis who receive outpatient care in VA facilities and have a suspected UTI.
✕Less likely to help
Patients without NB or those not seeking outpatient care for suspected UTIs may not benefit from this intervention.
What this research studies
This project targets veterans with bladder problems due to spinal cord injury or multiple sclerosis and tests a patient-centered antibiotic stewardship approach in outpatient clinics. It will combine new ways of guiding clinicians with patient-facing components to reduce misdiagnosis and inappropriate antibiotic use for suspected UTIs. The study will occur in Veterans Affairs outpatient settings, aiming to improve accuracy of diagnoses, antibiotic choices, and patient outcomes while reducing resistance risks. By focusing on NB patients, it seeks practical improvements that can be adopted in real-world VA care.
Why it matters
Potential benefit: If successful, patients could receive more accurate UTI diagnoses, safer antibiotic use, and better quality of life through fewer side effects and resistance.
How similar studies have gone: Prior antibiotic stewardship approaches have improved UTI management in other populations, suggesting potential for success in NB patients with outpatient care.
Where this research is happening
-
VA Eastern Colorado Health Care System
Aurora, United States Active
Researchers
- Principal investigator: Fitzpatrick, Margaret a — VA Eastern Colorado Health Care System
- Study coordinator: Fitzpatrick, Margaret a
Related research
Other NIH-funded projects on the same topics.
-
New ways to stop urinary tract infections by blocking bacterial adhesion
A study to test new methods that prevent bacteria from sticking to urinary tract tissues and devices, potentially stopping infections before they start.
-
Hybridization capture sequencing to quickly identify canine urinary pathogens and resistance genes
A new sequencing approach directly from dog urine aims to rapidly identify bacteria causing urinary infections and their drug-resistance profiles to guide treatment.
-
Enterococcal Proteases and CAUTI: How the body’s environment activates bacteria to cause infections
A small grant is exploring how two enzymes from Enterococcus faecalis interact with the urine environment to drive catheter-associated urinary tract infections and why these infections are hard to treat.
-
Daily nitrofurantoin with or without bladder cauterization to prevent recurrent bladder infections in women
This study tests two approaches to prevent recurrent bladder infections in women: taking a low-dose antibiotic every day versus adding a bladder cauterization procedure plus the same daily antibiotic.
-
New bacterial pathway that helps cause bladder infections
Researchers are exploring how bacteria steal nutrients in the bladder and how the body fights them to help people with urinary tract infections.
-
New oral antifungal for tough Candida UTIs
A Johns Hopkins team is testing a new oral antifungal medicine called fungerps to treat urinary tract infections caused by azole-resistant Candida fungi.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.